Salute e Benessere

Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with…

®, product code: JS001), in combination with bevacizumab for the first-line treatment of advanced hepatocellular carcinoma (“HCC”) has met the pre-defined efficacy boundary. Junshi Biosciences plans to submit a supplemental new drug application (“NDA”) for this indication to the regulatory authorities in the near future. Liver cancer is a common malignant tumor of the digestive system worldwide, and the predominant pathological type is HCC (accounting for about 90%). According to the...
Nasdaq GlobeNewswire
12/06/2024

UAE Workplaces Still Most Engaged In MENA Region; Surging Confidence In The…

These rates outpace the global average of 23% and are well above the average 14% employee engagement rate in the MENA region. Notably, engagement rates are similar for employees across age groups. However, fewer employees older than 35 (56%) are not engaged, compared to 62% of not engaged employees younger than 35. These rates outpace the global average of 23% and are well above the average 14% employee engagement rate in the MENA region. Notably, engagement rates are similar for employees...
PR Newswire
12/06/2024

Novo Nordisk Foundation and the Wellcome Trust award a grant of up to DKK 585…

AEGIS is led by the evolutionary geneticist Professor Eske Willerslev from the University of Copenhagen and University of Cambridge. The initiative aims to decode and understand how ecosystems and crops have responded and adapted to past environmental perturbations and is driven by the aspiration to create a more sustainable future by enhancing crop resilience and agroecosystem sustainability. AEGIS is led by the evolutionary geneticist Professor Eske Willerslev from theUniversity of...
PR Newswire
12/06/2024

Global Anti-Radiation Drugs Market to Register Incremental Growth at a CAGR of…

Key Takeaways from the Anti-Radiation Drugs Market Report Key Takeaways from the Anti-Radiation Drugs Market Report To read more about the latest highlights related to the anti-radiation drugs market, get a snapshot of the key highlights entailed in theGlobal Anti-Radiation Drugs Market Report Anti-Radiation Drugs Overview Anti-radiation drugs are pharmaceutical compounds designed to mitigate the damaging effects of radiation exposure on the human body. These drugs work by...
PR Newswire
11/06/2024

Voting Rights and Shares Capital of the Company

In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)PARIS, June11, 2024(GLOBE NEWSWIRE) --Market: Euronext Paris / Nasdaq Euronext Compartment: BISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website:www.nanobiotix.comDateNumber of Shares OutstandingTotal number of voting rightsTotal voting rights,...
Nasdaq GlobeNewswire
11/06/2024

Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in…

Recognized by the FDA as an excellent model for toxicology, small breeds of miniature domestic pigs known as minipigs share strong similarities with humans in crucial aspects such as drug metabolism, skin structure, genetics, and physiological mechanisms. In this preliminary safety study, minipigs received a single subcutaneous injection of LPT-CBD and were closely monitored for pharmacokinetics and basic safety parameters over one month. Encouragingly, the animals all exhibited good...
PR Newswire
11/06/2024

Transactions with shares and linked securities in Genmab A/S made by managerial…

Company Announcement COPENHAGEN, Denmark; June 11, 2024 –Genmab A/S(Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons.The company's managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish...
Nasdaq GlobeNewswire
11/06/2024

Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for…

"We are pleased to announce that the pivotal phase 2b/3 trial recruitment is completed, as this means that the results and outcome of the trial will be soon available," said Adrian McNicholl, Chief of Clinical Operations at Laminar Pharmaceuticals. The trial is expected to reach the trigger event for interim analysis in July 2024, which would provide an unblinded readout the last quarter of this year. "If idroxioleic acid is able to show compelling evidence demonstrating…
PR Newswire
11/06/2024

IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2024

Aggregatedpresentationbydayandbymarket Statement of transactions in own shares from June 3 to June 7, 2024 Name of issuerIdentificationcodeof issuer (Legal Entity Identifier)Day of transactionIdentificationcodeof financial instrumentAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares *Market (MIC Code)IPSEN...
Nasdaq GlobeNewswire
11/06/2024

Global Pet Furniture Market to Hit $10.65 billion by 2031: Coherent Market…

Market Dynamics: Market Dynamics: The growth of the global pet furniture market is primarily driven by rising pet humanization as well as increasing number of nuclear & blended families globally. According to the US Pet Owners Survey 2021 by the American Pet Products Association (APPA), around 90.5 million households inthe United Statesowned a pet as of 2021. Pets are considered as family members by majority of owners, which has increased the spending towards high-quality pet...
PR Newswire
11/06/2024

Osteotec and TriMed, Inc., agree distribution partnership for the Osteotec…

This collaboration, launched in February, signifies a major advance in Osteotec's mission to extend the reach of its product portfolio across the United States, with a special focus on delivering its flagship product, the Osteotec Silicone Finger Implant. This collaboration, launched in February, signifies a major advance in Osteotec's mission to extend the reach of its product portfolio acrossthe United States, with a special focus on delivering its flagship product, the Osteotec Silicone...
PR Newswire
11/06/2024

Dunaliella Salina Market to Reach $69.60 Million by 2031--Exclusive Report by…

Dunaliella is a genus of the algae family Dunaliellaceae. Dunaliella salina is a unicellular, green, halophilic microalgae species generally found in environments with high salt concentrations. Dunaliella salina's rich nutritional profile of high-quantity antioxidants, along with a vast spectrum of vital phytonutrients, makes it an active ingredient in the nutritional supplements and cosmetics industries. Natural beta-carotene from Dunaliella salina contains pro-vitamin A, which is converted to…
PR Newswire
11/06/2024

Flow Cytometry Market Surges to $10.3 Billion by 2032, Driven by 9.2% CAGR…

Browse in-depth TOC on "Flow Cytometry Market" Browse in-depth TOC on "Flow Cytometry Market" 713 - Tables 56 - Figures 559 - Pages Innovative Advancements Propel Growth In the dynamic global flow cytometry market, the introduction of cutting-edge technological advancements propels market expansion by catering to the demand for enhanced workflow efficiency and superior performance. Key players are continually innovating to develop and commercialize advanced flow cytometry...
PR Newswire
11/06/2024

Pfizer Reflects on 175-Year Global Legacy and Decades of Regional Breakthroughs

Patrick van der Loo, Regional President of Pfizer MERA, commented: "As we come together to mark this momentous milestone, today is an opportunity to acknowledge the endless global breakthroughs we have led over the past 175 years and the immense contributions that we have made to the regional medical landscape over the last 65 years. We are incredibly honored to partner with public sector leaders and to be strategic contributors in driving national healthcare agendas forward, bringing…
PR Newswire
11/06/2024

Blood Brain Barrier Market Untapped Growth Opportunities Analysis - Latest…

Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/2527 Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/2527 The Blood-Brain Barrier (BBB) market refers to the industry focused on developing, researching, and commercializing technologies, therapies, and strategies aimed at understanding, modifying, and interacting with the blood-brain barrier. The blood-brain barrier (BBB) is a selective permeability barrier that isolates...
PR Newswire
11/06/2024

Leo Cancer Care to Use Series C Financing to Grow Global Footprint

This investment highlights increasing confidence investors have in the team and the product, which is offering a "more human" way to administer radiation therapy to patients with a range of cancers. The unique upright patient positioning and CT imaging system, named Marie® after Nobel laureate and radioactivity research pioneerMarie Curie, utilizes a fixed radiation beam with patients rotated slowly and smoothly to different beam angles as treatment is administered. The...
PR Newswire
11/06/2024

ZINZINO AB (PUBL): Zinzino announces Serbia as next step in its global expansion

Market analysis shows that direct selling is popular among Serbian consumers and a natural way of selling for entrepreneurs seeking extra income. Digital commerce is growing rapidly, and more than two-thirds of the Serbian population use social media daily. Social selling combined with Zinzino's digital toolbox creates favorable conditions for their distributors to reach new customers in Serbia. Market analysis shows that direct selling is popular among Serbian consumers and a natural way of...
PR Newswire
11/06/2024

The 1000 Miglia 2024 has started

"The wait before the race is always nerve-wracking," said Andrea Vesco, in the hunt for his fourth consecutive victory at the 1000 Miglia, from the cockpit of the 1929 Alfa Romeo 6C SS Spider Zagato. "Let's hope it doesn't keep raining so we can pull down the top, but in any case once we get going I hope we settle into the race well as always." "The wait before the race is always nerve-wracking," said Andrea Vesco , in the hunt for his fourth consecutive victory at…
PR Newswire
11/06/2024

FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for…

Foralumab, a fully human anti-CD3 monoclonal antibody, is a biological drug candidate shown to cause T regulatory (Treg) cell induction when dosed intranasally. At present, ten (10) na-SPMS patients have been dosed in an Intermediate-Sized Patient Population Expanded Access (ISPPEA) Program with clinically meaningful reduction in fatigue scores (MFIS) in 70% of patients, and stability of disease noted within six months in all ten patients. In addition, intranasal foralumab is currently being...
Nasdaq GlobeNewswire
11/06/2024

Cumulus Neuroscience to Partner with The Digital Medicine Society (DiMe) to…

Cumulus will participate in the DATAcc by DiMe Building the Business Case for Digital Endpoints project, which will convene leaders from across the field to establish shared industry benchmarks for evaluating the return on investment (ROI) of digital endpoints in the development of drugs, medical devices, and other regulated interventions. Outputs of the project will include a value framework, industry benchmarking tools, ROI forecasting models, and a modular template to support innovators…
PR Newswire
11/06/2024

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9…

New sponsored testing program leverages Myriad's MyChoice Tests for patients with high-grade serous ovarian cancer Myriad Genetics, Inc.(NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with GSK aimed at improving access to homologous recombination deficiency (HRD) diagnostic testing for high-grade serous ovarian cancer (HGSOC) patients. A new sponsored testing program leveraging Myriad's MyChoice HRD Plus and MyChoice CDx Plus Tests...
Nasdaq GlobeNewswire
11/06/2024

Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of…

Company announcement, Helsinki, 11 June 2024 at 2 PM (EEST)Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act Nexstim Plc (NXTMH:HEX) (”Nexstim” or ”Company”) has received a notification pursuant to chapter 9, section 5 of the Securities Market Act from Kyösti Kakkonen on 10 June 2024.The notification is based on the amendment to the Securities Market Act effective April 19, 2024, requiring shareholders to notify the...
Nasdaq GlobeNewswire
11/06/2024

Ethyl Cyanoacetate Market worth $184 million by 2029 - Exclusive Report by…

140 – Tables60 – Figures200 – Pages 140 – Tables 60 – Figures 200 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34701457 Pharmaceuticals, by application, is expected to be the most significant Ethyl cyanoacetate Market segment during the forecast period. Pharmaceuticals has emerged as the fastest-growing end-use industry in the Ethyl cyanoacetate market because it serves as a crucial intermediate in the synthesis of various...
PR Newswire
11/06/2024

Augnito Announces Strategic Investment to Accelerate Digital Health Innovation

Augnito is at the forefront of SaaS innovation, providing state-of-the-art multi-lingual speech recognition, generative AI, and natural language processing technology to healthcare organizations worldwide. The company's suite of advanced voice-based solutions employs human-centric design principles to meet the evolving needs of both healthcare providers and patients. Augnito is at the forefront of SaaS innovation, providing state-of-the-art multi-lingual speech recognition, generative AI, and...
PR Newswire
11/06/2024
Altri  Comunicati